ASND
Ascendis Pharma AS
228.00$
+0.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -10.8% | -64.3% | +19.4% | -2.3% | -35.5% | -90.0% | -35.7% | +11.1% | +52,475.0% | -48.5% | -40.7% | -30.1% | +11.8% | -11.2% | -35.5% | +92.0% | -80.6% | +39.4% | +37.0% | +8.9% | +340.0% | +39.4% | -9.8% | +148.2% | +49.7% | +46.7% | +41.1% | +1.4% | +186.7% | -30.4% | -62.5% | +60.7% | +200.7% | -42.0% | +56.6% | +35.2% | +14.8% | +2.2% | +37.6% | – | |
| – | -6.2% | +22.9% | +18.6% | +30.8% | +1.6% | +464.6% | +917,160.3% | +522,877.1% | -100.0% | – | – | -100.0% | – | – | +10.5% | +0.8% | +189.0% | – | – | – | – | +20.5% | -74.4% | +55.9% | +201.9% | -9.6% | +179.8% | -42.9% | +163.4% | -61.1% | +51.5% | -2.3% | +25.2% | +24.9% | +79.5% | -28.9% | +21.7% | -20.5% | +49.4% | – | |
| – | -10.8% | -64.3% | +19.4% | -2.3% | -35.5% | -90.0% | -35.7% | +11.1% | +52,475.0% | -48.5% | -850.2% | – | +11.8% | -2,305.4% | – | – | – | – | +37.0% | +8.9% | +23.5% | +87.9% | +96.5% | +168.0% | +30.8% | +62.9% | +19.0% | +17.9% | +190.9% | -25.3% | -72.2% | +90.1% | +242.9% | -47.8% | +51.7% | +51.1% | +14.0% | +5.1% | +36.5% | – | |
| – | +21.1% | +3.1% | +6.2% | +32.8% | -3.6% | +8.9% | +31.7% | -21.7% | +20.6% | +34.9% | -14.5% | +5.5% | +8.7% | +14.4% | +10.5% | +0.8% | +18.3% | +16.4% | -5.5% | -29.5% | +11.7% | +26.7% | +8.6% | +7.8% | +11.5% | -2.3% | -1.0% | +6.1% | -18.4% | -22.2% | +18.1% | -11.9% | +7.8% | +9.2% | -16.9% | -7.1% | +12.1% | -23.1% | +29.5% | – | |
| – | +24.4% | +1.2% | -2.8% | -12.1% | +43.9% | +14.1% | +12.1% | +30.0% | +23.2% | +24.6% | +5.0% | -8.8% | +70.8% | +4.9% | +16.1% | -15.8% | +16.6% | +82.4% | -5.1% | +11.1% | +23.0% | -1.8% | +19.3% | +7.2% | -6.8% | +17.7% | +5.6% | -11.1% | +2.3% | +13.0% | +0.0% | -5.8% | +15.6% | +21.4% | +10.5% | +5.7% | +20.9% | +7.6% | +18.2% | – | |
| – | +21.5% | +2.8% | +4.9% | +27.1% | +0.7% | +9.6% | +29.1% | -15.7% | +21.0% | +33.1% | -11.2% | +2.7% | +19.7% | -73.4% | +16.1% | -15.8% | -607.8% | – | -5.4% | -17.4% | +16.2% | +14.6% | +12.5% | +7.6% | +4.5% | +4.5% | +1.5% | -0.1% | -11.5% | -11.2% | +14.8% | -9.1% | +11.3% | +17.6% | -4.3% | +0.4% | +15.5% | -2.1% | +22.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -27,309.4% | – | – | -10.9% | +157.3% | +151.5% | – | |
| – | +795.1% | -44.6% | +262.0% | -54.9% | +279.8% | -34.3% | -99.9% | +600.0% | +39,390.5% | -98.8% | +4,278.4% | -95.7% | +5,508.2% | -97.8% | +2,202.5% | +288.4% | -1.5% | -97.8% | +1,297.1% | -92.8% | +5,057.1% | -88.1% | +74.7% | +337.2% | +73.8% | -86.3% | -5.1% | +162.7% | +179.6% | +12.6% | -74.6% | +29.2% | +123.4% | -20.9% | -26.3% | -40.3% | +211.3% | +11.3% | -78.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -163.6% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,380.0% | – | -119.5% | – | – | -75.8% | -133.1% | – | +797.7% | -56.7% | -90.9% | +345.4% | +6.4% | -2.2% | +262.7% | -6.0% | +87.8% | -10,238.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -67.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2,400.7% | – | -40.4% | +187.5% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.